For years, Merck & Co. has had an upper hand over its chief cancer drug competitor Bristol Myers Squibb. In March, however, Bristol Myers beat …

Dive Brief: An experimental psoriasis drug developed by Bristol Myers Squibb maintained its effectiveness over more than a year of treatment in a clinical trial …

Dive Brief: The Food and Drug Administration will decide whether to approve Bristol Myers Squibb’s cancer cell therapy Breyanzi for earlier use by late June, …